« previous next »
Pages: [1]

Author Topic: (Abst.) Second-line therapy for patients w/RRMS: A review of guidelines (Canada)  (Read 48 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Second-line therapy for patients w/RRMS: A review of guidelines (Canada)
« on: November 14, 2019, 09:25:59 pm »
From PubMed (November 14, 2019)--"Second-line therapy for patients with relapsing-remitting multiple sclerosis:  A review of guidelines" from the Canadian Agency for Drugs and Technologies in Health:


https://www.ncbi.nlm.nih.gov/pubmed/31714703
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
159 Views 		Last post November 24, 2016, 08:04:14 am
by agate
0 Replies
96 Views 		Last post March 12, 2017, 03:27:10 pm
by agate
0 Replies
122 Views 		Last post May 17, 2017, 09:58:16 am
by agate
0 Replies
105 Views 		Last post September 21, 2018, 07:18:16 am
by agate
0 Replies
29 Views 		Last post May 27, 2022, 09:38:47 pm
by agate